Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolus (EOLS) EBIT (2017 - 2026)

Evolus filings provide 9 years of EBIT readings, the most recent being -$6.8 million for Q1 2026.

  • On a quarterly basis, EBIT rose 54.86% to -$6.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$24.3 million, a 40.14% increase, with the full-year FY2025 number at -$32.7 million, up 5.08% from a year prior.
  • EBIT hit -$6.8 million in Q1 2026 for Evolus, down from $4.2 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $4.2 million in Q4 2025 to a low of -$21.3 million in Q2 2022.
  • Median EBIT over the past 5 years was -$11.5 million (2025), compared with a mean of -$11.1 million.
  • Biggest five-year swings in EBIT: tumbled 292.47% in 2022 and later skyrocketed 282.37% in 2025.
  • Evolus' EBIT stood at -$10.6 million in 2022, then increased by 18.82% to -$8.6 million in 2023, then surged by 73.2% to -$2.3 million in 2024, then skyrocketed by 282.37% to $4.2 million in 2025, then crashed by 262.27% to -$6.8 million in 2026.
  • The last three reported values for EBIT were -$6.8 million (Q1 2026), $4.2 million (Q4 2025), and -$11.5 million (Q3 2025) per Business Quant data.